HEADER HYDROLASE 23-APR-04 1T32 TITLE A DUAL INHIBITOR OF THE LEUKOCYTE PROTEASES CATHEPSIN G AND CHYMASE TITLE 2 WITH THERAPEUTIC EFFICACY IN ANIMALS MODELS OF INFLAMMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN G; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CG; COMPND 5 EC: 3.4.21.20; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HUMAN KEYWDS INFLAMMATION INHIBITOR SERINE PROTEASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.DE GARAVILLA,M.N.GRECO,E.C.GIARDINO,G.I.WELLS,B.J.HAERTLEIN, AUTHOR 2 J.A.KAUFFMAN,T.W.CORCORAN,C.K.DERIAN,A.J.ECKARDT,W.M.ABRAHAM, AUTHOR 3 N.SUKUMAR,Z.CHEN,A.O.PINEDA,F.S.MATHEWS,E.DI CERA,P.ANDRADE-GORDON, AUTHOR 4 B.P.DAMIANO,B.E.MARYANOFF REVDAT 4 23-AUG-23 1T32 1 REMARK REVDAT 3 24-FEB-09 1T32 1 VERSN REVDAT 2 10-MAY-05 1T32 1 JRNL REVDAT 1 01-MAR-05 1T32 0 JRNL AUTH L.DE GARAVILLA,M.N.GRECO,N.SUKUMAR,Z.W.CHEN,A.O.PINEDA, JRNL AUTH 2 F.S.MATHEWS,E.DI CERA,E.C.GIARDINO,G.I.WELLS,B.J.HAERTLEIN, JRNL AUTH 3 J.A.KAUFFMAN,T.W.CORCORAN,C.K.DERIAN,A.J.ECKARDT, JRNL AUTH 4 B.P.DAMIANO,P.ANDRADE-GORDON,B.E.MARYANOFF JRNL TITL A NOVEL, POTENT DUAL INHIBITOR OF THE LEUKOCYTE PROTEASES JRNL TITL 2 CATHEPSIN G AND CHYMASE: MOLECULAR MECHANISMS AND JRNL TITL 3 ANTI-INFLAMMATORY ACTIVITY IN VIVO. JRNL REF J.BIOL.CHEM. V. 280 18001 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15741158 JRNL DOI 10.1074/JBC.M501302200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.HOF,I.MAYR,R.HUBER,E.KORZUS,J.POTEMPA,J.TRAVIS,J.C.POWERS, REMARK 1 AUTH 2 W.BODE REMARK 1 TITL THE 1.8 A CRYSTAL STRUCTURE OF HUMAN CATHEPSIN G IN COMPLEX REMARK 1 TITL 2 WITH SUC-VAL-PRO-PHEP-(OPH)2: A JANUS-FACED PROTEINASE WITH REMARK 1 TITL 3 TWO OPPOSITE SPECIFICITIES REMARK 1 REF EMBO J. V. 15 5481 1996 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 8896442 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.8 REMARK 3 NUMBER OF REFLECTIONS : 14436 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 714 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2169 REMARK 3 BIN FREE R VALUE : 0.2893 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 67 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1787 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 261 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1T32 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-APR-04. REMARK 100 THE DEPOSITION ID IS D_1000022249. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15108 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 51.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.19900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1CGH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, SODIUM HEPES, SODIUM REMARK 280 ACETATE, AMMONIUM SULFATE, 2-PROPANOL, PH 7.0, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 296.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.40000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.65000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.65000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.40000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 SER A 36A REMARK 475 PRO A 36B REMARK 475 ALA A 37 REMARK 475 GLY A 38 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 28 -7.49 -57.88 REMARK 500 GLN A 36 98.67 77.11 REMARK 500 SER A 36A -61.01 -13.40 REMARK 500 PRO A 36B 109.69 -35.38 REMARK 500 SER A 40 131.40 -176.39 REMARK 500 HIS A 71 -57.68 -123.90 REMARK 500 ALA A 189 161.29 175.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 905 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 906 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OHH A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CGH RELATED DB: PDB REMARK 900 THE 1.8 A CRYSTAL STRUCTURE OF HUMAN CATHEPSIN G IN COMPLEX WITH REMARK 900 SUC-VAL-PRO-PHEP-(OPH)2: A JANUS-FACED PROTEINASE WITH TWO OPPOSITE REMARK 900 SPECIFICITIES DBREF 1T32 A 16 239 UNP P08311 CATG_HUMAN 21 244 SEQRES 1 A 224 ILE ILE GLY GLY ARG GLU SER ARG PRO HIS SER ARG PRO SEQRES 2 A 224 TYR MET ALA TYR LEU GLN ILE GLN SER PRO ALA GLY GLN SEQRES 3 A 224 SER ARG CYS GLY GLY PHE LEU VAL ARG GLU ASP PHE VAL SEQRES 4 A 224 LEU THR ALA ALA HIS CYS TRP GLY SER ASN ILE ASN VAL SEQRES 5 A 224 THR LEU GLY ALA HIS ASN ILE GLN ARG ARG GLU ASN THR SEQRES 6 A 224 GLN GLN HIS ILE THR ALA ARG ARG ALA ILE ARG HIS PRO SEQRES 7 A 224 GLN TYR ASN GLN ARG THR ILE GLN ASN ASP ILE MET LEU SEQRES 8 A 224 LEU GLN LEU SER ARG ARG VAL ARG ARG ASN ARG ASN VAL SEQRES 9 A 224 ASN PRO VAL ALA LEU PRO ARG ALA GLN GLU GLY LEU ARG SEQRES 10 A 224 PRO GLY THR LEU CYS THR VAL ALA GLY TRP GLY ARG VAL SEQRES 11 A 224 SER MET ARG ARG GLY THR ASP THR LEU ARG GLU VAL GLN SEQRES 12 A 224 LEU ARG VAL GLN ARG ASP ARG GLN CYS LEU ARG ILE PHE SEQRES 13 A 224 GLY SER TYR ASP PRO ARG ARG GLN ILE CYS VAL GLY ASP SEQRES 14 A 224 ARG ARG GLU ARG LYS ALA ALA PHE LYS GLY ASP SER GLY SEQRES 15 A 224 GLY PRO LEU LEU CYS ASN ASN VAL ALA HIS GLY ILE VAL SEQRES 16 A 224 SER TYR GLY LYS SER SER GLY VAL PRO PRO GLU VAL PHE SEQRES 17 A 224 THR ARG VAL SER SER PHE LEU PRO TRP ILE ARG THR THR SEQRES 18 A 224 MET ARG SER HET SO4 A 902 5 HET SO4 A 903 5 HET SO4 A 904 5 HET SO4 A 905 5 HET SO4 A 906 5 HET OHH A 901 49 HETNAM SO4 SULFATE ION HETNAM OHH 2-[3-({METHYL[1-(2-NAPHTHOYL)PIPERIDIN-4- HETNAM 2 OHH YL]AMINO}CARBONYL)-2-NAPHTHYL]-1-(1-NAPHTHYL)-2- HETNAM 3 OHH OXOETHYLPHOSPHONIC ACID FORMUL 2 SO4 5(O4 S 2-) FORMUL 7 OHH C40 H35 N2 O6 P FORMUL 8 HOH *261(H2 O) HELIX 1 1 ALA A 55 TRP A 59 5 5 HELIX 2 2 ARG A 164 PHE A 172 1 9 HELIX 3 3 PHE A 234 ARG A 243 1 10 SHEET 1 A 7 ARG A 20 GLU A 21 0 SHEET 2 A 7 ARG A 156 ARG A 161 -1 O GLU A 157 N ARG A 20 SHEET 3 A 7 LEU A 135 GLY A 140 -1 N CYS A 136 O LEU A 160 SHEET 4 A 7 PRO A 198 CYS A 201 -1 O LEU A 200 N THR A 137 SHEET 5 A 7 VAL A 204 TYR A 215 -1 O VAL A 204 N CYS A 201 SHEET 6 A 7 GLU A 226 ARG A 230 -1 O VAL A 227 N TYR A 215 SHEET 7 A 7 GLN A 180 VAL A 183 -1 N VAL A 183 O GLU A 226 SHEET 1 B 7 MET A 30 ILE A 35 0 SHEET 2 B 7 ARG A 41 ARG A 48 -1 O CYS A 42 N LEU A 33 SHEET 3 B 7 PHE A 51 THR A 54 -1 O LEU A 53 N PHE A 45 SHEET 4 B 7 MET A 104 LEU A 108 -1 O LEU A 106 N VAL A 52 SHEET 5 B 7 GLN A 81 ARG A 90 -1 N ILE A 89 O LEU A 105 SHEET 6 B 7 ILE A 64 LEU A 68 -1 N VAL A 66 O ILE A 83 SHEET 7 B 7 MET A 30 ILE A 35 -1 N GLN A 34 O ASN A 65 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.04 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.04 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.04 CISPEP 1 PRO A 224 PRO A 225 0 -0.10 SITE 1 AC1 9 ARG A 20 GLU A 21 ARG A 114 ASN A 119 SITE 2 AC1 9 ARG A 156 HOH A1045 HOH A1078 HOH A1127 SITE 3 AC1 9 HOH A1201 SITE 1 AC2 5 ARG A 170 ARG A 178 ARG A 179 LYS A 217 SITE 2 AC2 5 HOH A1232 SITE 1 AC3 2 ARG A 75 ARG A 76 SITE 1 AC4 6 ARG A 86 ARG A 97 GLN A 107 PRO A 132 SITE 2 AC4 6 ARG A 147 HOH A1200 SITE 1 AC5 7 ARG A 86 ARG A 131 SER A 145 MET A 146 SITE 2 AC5 7 ARG A 147 HOH A1094 HOH A1211 SITE 1 AC6 23 HIS A 57 ILE A 99 ARG A 166 LEU A 169 SITE 2 AC6 23 PHE A 172 ASP A 176 PRO A 177 ARG A 178 SITE 3 AC6 23 ALA A 190 LYS A 192 GLY A 193 SER A 195 SITE 4 AC6 23 SER A 214 TYR A 215 GLY A 216 LYS A 217 SITE 5 AC6 23 SER A 218 GLU A 226 HOH A1063 HOH A1087 SITE 6 AC6 23 HOH A1110 HOH A1130 HOH A1137 CRYST1 38.800 62.300 79.300 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025773 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016051 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012610 0.00000